Definition of an epitope on NS3 recognized by human CD4+ cytotoxic T lymphocyte clones cross-reactive for dengue virus types 2, 3, and 4

Virology

Volumn 240, Issue 2, 1998, Pages 169-174

  Kurane, Ichiro ^a   Zeng, Lingling ^b   Brinton, Margo A ^b   Ennis, Francis A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE; EPITOPE; HLA DR ANTIGEN; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENGUE; DENGUE VIRUS; EPITOPE MAPPING; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; SEROTYPE;

ANIMALIA; ARBOVIRUS; DENGUE VIRUS; INVERTEBRATA; RNA VIRUSES;

EID: 0032518477     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8925     Document Type: Article

References (20)

1. Bodmer J. G., Marsh G. E., Albert E. D., Bodmer W. F., Dupont B., Erlich H. A., Mach B., Mayr W. R., Parham P., Sasazuki T., Schreuder G. M. Th., Strominger J. L., Svejgaard A., Terasaki P. I. Nomenclature for factors of the HLA system, 1994. Hum. Immunol. 41:1994;1-20.
2. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 21:1968;77-89.
3. Chicz R. M., Urban R. G., Lane W. S., Gorga J. C., Stern L. J., Vignali D. A. A., Strominger J. L. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature (London). 358:1992;764-768.
4. Fu J., Tan B., Yap E., Chan Y., Tan Y. Full-length cDNA sequence of dengue type 1 virus (Singapore strain S275/90). J. Virol. 188:1992;953-958.
5. +. J. Virol. 67:1993;5962-5967.
6. Halstead, S. B. 1980, Immunological parameters of togavirus disease syndrome, In, The Togaviruses: Biology, Structure, Replication, 107, 173, Academic Press, New York.
7. Halstead S. B. Pathogenesis of dengue: Challenges to molecular biology. Science. 239:1988;476-481.
8. Innis B. L., Eckels K. H., Kraiselburg E., Dubois D. R., Meadors G. F., Gubler D. L., Burks D. S., Bancroft W. H. Virulence of a live dengue vaccine candidate: A possible new marker of dengue virus attention. J. Infect. Dis. 158:1988;876-880.
9. Irie K., Mohan P., Sasaguri M., Putnak R., Padmanabhan R. Sequence analysis of cloned dengue virus type 2 genome (New Guinea-C strain). Gene. 75:1989;197-211.
10. Kurane I., Ennis F. A. Immunity and immunopathology in dengue virus infections. Sem. Immunol. 4:1992;121-127.
11. Kurane I., Ennis F. A. Cytotoxic T lymphocytes in dengue virus infection. Curr. Top. Microbiol. Immunol. 189:1994;93-108.
12. Kurane I., Meager A., Ennis F. A. Dengue virus-specific human T cell clones. Serotype cross-reactive proliferation, interferon γ production, and cytotoxic activity. J. Exp. Med. 170:1989a;763-775.
13. Kurane I., Innis B. L., Nisalak A., Hoke C., Nimmannitya S., Meager A., Janus J., Ennis F. A. Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J. Clin. Invest. 83:1989b;506-513.
14. Kurane I., Brinton M. A., Samson A. L., Ennis F. A. Dengue virus-specific, human CD4+ CD8- cytotoxic T-cell clones: Multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J. Virol. 65:1991;1823-1828.
15. Livingston P. G., Kurane I., Dai L.-C., Okamoto Y., Lai C.-J., Men R., Karaki S., Takiguchi M., Ennis F. A. Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones: Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities. J. Immunol. 154:1995;1287-1295.
16. Livingston P. G., Kurane I., Lai C.-J., Bray M., Ennis F. A. Recognition of envelope protein by dengue virus serotype specific human CD4+ CD8- cytotoxic T cell clones. J. Virol. 68:1994;3283-3288.
17. Mackow E., Makino Y., Zhao B., Zhang Y., Markoff L., Buckler-White A., Guiler M., Chanock R., Lai C.-J. The nucleotide sequence of dengue type 4 virus: Analysis of genes coding for nonstructural proteins. Virology. 159:1987;217-228.
18. Monath T. P. Dengue: The risk to developed and developing countries. Proc. Natl. Acad. Sci. USA. 91:1994;2395-2400.
19. Osatomi K., Sumitoshi H. Complete nucleotide sequence of dengue type 3 virus genome RNA. Virology. 176:1990;643-647.
20. Zeng L. L., Kurane I., Okamoto Y., Ennis F. A., Brinton M. A. Identification of amino acids involved in recognition by dengue virus. NS3-specific, HLA-DR15-restricted cytotoxic CD4+ T-cell clones. J. Virol. 70:1996;3108-3117.